1. Home
  2. XENE
  3. XENE News

Latest Xenon Pharmaceuticals Inc. (XENE) News on January 19, 2025

Xenon Outlines Key Corporate Milestone Opportunities for 2025
XENE

GlobeNewswire

6 days ago

Xenon Outlines Key Corporate Milestone Opportunities for 2025

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
XENE

GlobeNewswire

12 days ago

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?
XENE

Zacks

a month ago

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
XENE

GlobeNewswire

a month ago

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
XENE

GlobeNewswire

2 months ago

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024

JPMorgan Selects These 2 Stocks as Must-Haves for 2025
XENE

TipRanks

2 months ago

JPMorgan Selects These 2 Stocks as Must-Haves for 2025

Xenon to Present at Upcoming Investor Conferences
XENE

GlobeNewswire

2 months ago

Xenon to Present at Upcoming Investor Conferences

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus
XENE

Zacks

2 months ago

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
XENE

GuruFocus.com

2 months ago

Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...

XENE

MT Newswires

2 months ago

Xenon Pharmaceuticals Q3 Net Loss Widens

XENE

Associated Press Finance

2 months ago

Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Reports Q3 2024 Financial Results and Business Update
XENE

GlobeNewswire

2 months ago

Xenon Reports Q3 2024 Financial Results and Business Update

Earnings To Watch: Xenon Pharmaceuticals Inc (XENE) Reports Q3 2024 Result
XENE

GuruFocus.com

2 months ago

Earnings To Watch: Xenon Pharmaceuticals Inc (XENE) Reports Q3 2024 Result

Xenon to Report Q3 2024 Financial Results on November 12, 2024
XENE

GlobeNewswire

2 months ago

Xenon to Report Q3 2024 Financial Results on November 12, 2024

Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52%
XENE

Zacks

3 months ago

Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52%

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe
XENE

Zacks

3 months ago

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

Xenon Pharmaceuticals Inc (XENE) Q2 2024 Earnings Call Highlights: Strategic Advances and ...
XENE

GuruFocus.com

3 months ago

Xenon Pharmaceuticals Inc (XENE) Q2 2024 Earnings Call Highlights: Strategic Advances and ...

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
XENE

GlobeNewswire

4 months ago

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference

XENE

MT Newswires

4 months ago

HC Wainwright Initiates Coverage on Xenon Pharmaceuticals With Buy Rating, $53 Price Target

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
XENE

GlobeNewswire

4 months ago

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress

Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now
XENE

Insider Monkey

4 months ago

Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now

We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely
XENE

Simply Wall St.

5 months ago

We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely

Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe
XENE

Zacks

5 months ago

Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe

XENE

MT Newswires

5 months ago

Xenon Pharmaceuticals Names Matthew Ronsheim Chief Operating Officer

Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
XENE

GlobeNewswire

5 months ago

Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer

Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down
XENE

Zacks

5 months ago

Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down

XENE

MT Newswires

5 months ago

Wedbush Adjusts Xenon Pharmaceuticals' PT to $49 From $50, Keeps Outperform Rating

XENE

MT Newswires

5 months ago

Xenon Pharmaceuticals Q2 Net Loss Widens

XENE

Associated Press Finance

5 months ago

Xenon Pharmaceuticals: Q2 Earnings Snapshot

Xenon Reports Q2 2024 Financial Results and Business Update
XENE

GlobeNewswire

5 months ago

Xenon Reports Q2 2024 Financial Results and Business Update

Xenon to Report Q2 2024 Financial Results on August 8, 2024
XENE

GlobeNewswire

6 months ago

Xenon to Report Q2 2024 Financial Results on August 8, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Could Be 24% Below Their Intrinsic Value Estimate
XENE

Simply Wall St.

6 months ago

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Could Be 24% Below Their Intrinsic Value Estimate

Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
XENE

Zacks

7 months ago

Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag

Is Xenon Pharmaceuticals Inc. (XENE) One of the Best Healthcare Stocks Under $50?
XENE

Insider Monkey

7 months ago

Is Xenon Pharmaceuticals Inc. (XENE) One of the Best Healthcare Stocks Under $50?

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
XENE

GlobeNewswire

7 months ago

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Shareholders Will Probably Not Have Any Issues With Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) CEO Compensation
XENE

Simply Wall St.

8 months ago

Shareholders Will Probably Not Have Any Issues With Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) CEO Compensation

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
XENE

GlobeNewswire

8 months ago

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting

Hedge Funds are Racking Up Shares of This Healthcare Stock
XENE

Insider Monkey

8 months ago

Hedge Funds are Racking Up Shares of This Healthcare Stock

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript
XENE

Insider Monkey

8 months ago

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript

XENE

GuruFocus.com

8 months ago

Xenon Pharmaceuticals Inc (XENE) Reports Increased Losses in Q1 2024, Despite Advancements in ...

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
XENE

Zacks

8 months ago

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

XENE

MT Newswires

8 months ago

Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating

XENE

MT Newswires

8 months ago

Xenon Pharmaceuticals Q1 Net Loss Narrows

XENE

Associated Press Finance

8 months ago

Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
XENE

GlobeNewswire

8 months ago

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
XENE

GlobeNewswire

8 months ago

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
XENE

GlobeNewswire

8 months ago

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock
XENE

Zacks

8 months ago

What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
XENE

GlobeNewswire

9 months ago

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
XENE

GlobeNewswire

9 months ago

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
XENE

GlobeNewswire

9 months ago

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
XENE

GlobeNewswire

9 months ago

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans
XENE

Simply Wall St.

10 months ago

Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
XENE

GlobeNewswire

10 months ago

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days

Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...
XENE

GuruFocus.com

10 months ago

Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
XENE

GlobeNewswire

10 months ago

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript
XENE

Insider Monkey

a year ago

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript

Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus
XENE

Zacks

a year ago

Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus

XENE

GuruFocus.com

a year ago

Xenon Pharmaceuticals Inc (XENE) Reports Full Year and Q4 2023 Financial Results

XENE

Associated Press Finance

a year ago

Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition
XENE

InvestorPlace

a year ago

3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition

Is Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Trading At A 39% Discount?
XENE

Simply Wall St.

a year ago

Is Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Trading At A 39% Discount?

XENE

Thomson Reuters StreetEvents

a year ago

Q4 2023 Columbia Sportswear Co Earnings Call

Columbia Sportswear (COLM) Reports Q4 Earnings: What Key Metrics Have to Say
XENE

Zacks

a year ago

Columbia Sportswear (COLM) Reports Q4 Earnings: What Key Metrics Have to Say

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story
XENE

Motley Fool

a year ago

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30
XENE

CNW Group

a year ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Capital One Financial Corporation (NYSE:COF) Q4 2023 Earnings Call Transcript
XENE

Insider Monkey

a year ago

Capital One Financial Corporation (NYSE:COF) Q4 2023 Earnings Call Transcript

Why Investors Need to Take Advantage of These 2 Oils-Energy Stocks Now
XENE

Zacks

a year ago

Why Investors Need to Take Advantage of These 2 Oils-Energy Stocks Now

Valley National Bancorp Full Year 2023 Earnings: EPS Misses Expectations
XENE

Simply Wall St.

a year ago

Valley National Bancorp Full Year 2023 Earnings: EPS Misses Expectations

XENE

Thomson Reuters StreetEvents

a year ago

Q4 2023 Sherwin-Williams Co Earnings Call

22 Largest Clothing Companies by Market Cap in the World
XENE

Insider Monkey

a year ago

22 Largest Clothing Companies by Market Cap in the World

Sherwin-Williams (SHW) Beats Q4 Earnings & Sales Estimates
XENE

Zacks

a year ago

Sherwin-Williams (SHW) Beats Q4 Earnings & Sales Estimates

Wall Street Bulls Look Optimistic About Allegro MicroSystems, Inc. (ALGM): Should You Buy?
XENE

Zacks

a year ago

Wall Street Bulls Look Optimistic About Allegro MicroSystems, Inc. (ALGM): Should You Buy?

Here's Why You Should Add Xenon (XENE) to Your Portfolio Now
XENE

Zacks

a year ago

Here's Why You Should Add Xenon (XENE) to Your Portfolio Now

Italy’s Leonardo Eyes Catalyst Role in Europe Defence Deals
XENE

Bloomberg

a year ago

Italy’s Leonardo Eyes Catalyst Role in Europe Defence Deals

Truist, Fifth Third Add to Bank Bond Spree With $4.5 Billion
XENE

Bloomberg

a year ago

Truist, Fifth Third Add to Bank Bond Spree With $4.5 Billion

Wall Street Analysts Think Xenon Pharmaceuticals (XENE) Could Surge 25.76%: Read This Before Placing a Bet
XENE

Zacks

a year ago

Wall Street Analysts Think Xenon Pharmaceuticals (XENE) Could Surge 25.76%: Read This Before Placing a Bet

Those who invested in Greif (NYSE:GEF) five years ago are up 91%
XENE

Simply Wall St.

a year ago

Those who invested in Greif (NYSE:GEF) five years ago are up 91%

Shell (SHEL) Inks 20-Year Purchase Deal With Ksi Lisims LNG
XENE

Zacks

a year ago

Shell (SHEL) Inks 20-Year Purchase Deal With Ksi Lisims LNG

Here's Why You Should Invest in Kirby (KEX) Stock Right Now
XENE

Zacks

a year ago

Here's Why You Should Invest in Kirby (KEX) Stock Right Now

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024

Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Bristol Myers' $4.1 Billion Deal For RayzeBio Sends RYZB Stock Soaring 100%
XENE

Investor's Business Daily

a year ago

Bristol Myers' $4.1 Billion Deal For RayzeBio Sends RYZB Stock Soaring 100%

Credit Acceptance Corporation Announces Expiration and Results of Tender Offer For Any and All of Its $400,000,000 Aggregate Principal Amount of 5.125% Senior Notes Due 2024
XENE

GlobeNewswire

a year ago

Credit Acceptance Corporation Announces Expiration and Results of Tender Offer For Any and All of Its $400,000,000 Aggregate Principal Amount of 5.125% Senior Notes Due 2024

Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

After losing 5.2% in the past year, Xenon Pharmaceuticals Inc. (NASDAQ:XENE) institutional owners must be relieved by the recent gain
XENE

Simply Wall St.

a year ago

After losing 5.2% in the past year, Xenon Pharmaceuticals Inc. (NASDAQ:XENE) institutional owners must be relieved by the recent gain

Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)

Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering

Share on Social Networks: